Metabolic Impact of Adult-Onset, Isolated, Growth Hormone Deficiency (AOiGHD) Due to Destruction of Pituitary Somatotropes
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Growth hormone (GH) inhibits fat accumulation and promotes protein accretion, therefore the fall in GH observed with weight gain and normal aging may contribute to metabolic dysfunction. To directly test this hypothesis a novel mouse model of adult onset-isolated GH deficiency (AOiGHD) was generated by cross breeding rat GH promoter-driven Cre recombinase mice (Cre) with inducible diphtheria toxin receptor mice (iDTR) and treating adult Cre(+/-),iDTR(+/-) offspring with DT to selectively destroy the somatotrope population of the anterior pituitary gland, leading to a reduction in circulating GH and IGF-I levels. DT-treated Cre(-/-),iDTR(+/-) mice were used as GH-intact controls. AOiGHD improved whole body insulin sensitivity in both low-fat and high-fat fed mice. Consistent with improved insulin sensitivity, indirect calorimetry revealed AOiGHD mice preferentially utilized carbohydrates for energy metabolism, as compared to GH-intact controls. In high-fat, but not low-fat fed AOiGHD mice, fat mass increased, hepatic lipids decreased and glucose clearance and insulin output were impaired. These results suggest the age-related decline in GH helps to preserve systemic insulin sensitivity, and in the context of moderate caloric intake, prevents the deterioration in metabolic function. However, in the context of excess caloric intake, low GH leads to impaired insulin output, and thereby could contribute to the development of diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Design and validation of the AOiGHD mouse model. (A) rGHp-Cre and iDTR transgenic mice were crossbred to generate mice that express the DTR in the GH-producing cells (somatotropes) of the anterior pituitary gland, (B) Analysis of DTR mRNA copy number in pituitary (PIT), pancreas (PAN), liver (LIV) and adipose tissue (FAT) from Cre+/−,DTR+/− mice (without DT treatment) reveals that DTR is expressed only in the pituitary (other tissues tested [but not shown] were muscle, spleen, brain, lung, kidney, skin, intestine, adrenal, testis, ovary), “No RT PIT” indicates PCR amplification of total pituitary mRNA which was not reversed transcribed. The tissue specific pattern of DTR mRNA matched that previously reported for Cre recombinase mRNA in rGHp-Cre Tg mice [7]. Cre+/−,DTR+/− mice are normal until treated with DT, which results in the destruction of the somatotrope population. (C) Gross morphology (I) and GH immunofluorescence of pituitary cross-sections (II) and enzymatically dispersed pituitary cells (III) from DT-treated Cre−/−,DTR+/− mice (controls, left panels) and DT-treated Cre+/−,DTR+/− mice (AOiGHD, right panels). GH immuno-positive cells appear red and cell nuclei appear blue (II and III). Somatotropes from DT treated Cre+/−,DTR+/− mice are enlarged, relative to DT treated controls (III arrows). (D) Percentage of GH immuno-positive cells in pituitaries from DT-treated Cre−/−,iDTR+/− mice and vehicle (V)- and DT-treated Cre+/−,DTR+/− mice (left), and pituitary GH mRNA (middle) and circulating GH (right), in DT-treated control and AOiGHD mice. (E) Liver IGF-I mRNA (left) and circulating total IGF-I (right). (F) Hypothalamic expression of GHRH. Analysis of circulating hormones and tissue expression analysis were conducted 7 months post DT treatment. Hormone mRNA copy numbers were adjusted by HPRT mRNA copy number to control for total RNA reverse transcribed and the efficiency of the reaction. (G) Impact of in vitro vehicle- (V) and DT-treatment (10ng/ml for 24h) on GH and prolactin mRNA levels in primary pituitary cell cultures from adult Cre−/−,DTR+/− and Cre+/−,DTR+/− mice, where values are the means of 3 independent experiments. Panels C–F represent data collected after 2 months post-DT treatment with n = 8–12 mice/group. Asterisks indicate values that differ from controls, *, p<0.05, ** p<0.01, and *** p<0.001.](https://figures.cochat.ai/paper-figures/5a7c0f46c7b940be95bb3aa767883e6b/metabolic-impact-of-adult-onset-isolated-growth-hormone-deficiency-aoighd-due-to-figure-1.jpg)
![Figure 2 Impact of 2 to 7 months of AOiGHD on metabolic endpoints in male mice fed a standard rodent chow diet. (A) Body weights (B) Relative fat depot (subcutaneous [SC], urogenital [UG], retroperitoneal [RP]) and liver (LIV) weight, of DT-treated Cre+/−,DTR+/− (AOiGHD) mice compared to DT-treated Cre−/−,DTR+/− controls set at 1. (C) Serum leptin levels measured 2 months post DT treatment in DT-treated Cre−/−,DTR+/− and vehicle-treated Cre+/−,DTR+/− mice (controls [ctrl]), compared to AOiGHD mice. (D) Percent total body weight of free fluid, fat and lean tissue weight measured by whole body NMR 2.5 months post DT treatment, using the MiniSpec LF50 (Bruker Optics, Germany). (E) Insulin tolerance tests (ITT, 0.75U/kg ip) and glucose tolerance tests (GTT, 2g/kg ip) conducted 2–3 months post DT treatment. (F) Glucose and insulin levels measured in serum samples (trunk blood) 7 month post DT treatment. Values are means +/− SEM, of n = 8–12 mice/group. Asterisks indicate values which significantly differ from controls, * p<0.05, *** P<0.001. a, indicates a significant effect of age (p<0.05), independent of GH status. Data presented in panels A–B and E–F are from AOiGHD and littermate controls, where DT was delivered by multiple ip injections, while data shown in panel D is from a separate set of mice (2.5 months post-DT treatment), where DT was delivered by osmotic minipump as described in Fig. 3. It should be noted that these metabolic endpoints did not differ between Cre+/−,DTR+/− and Cre−/−,DTR+/− mice not treated with DT, as shown in Fig. S1.](https://figures.cochat.ai/paper-figures/1839d2f0cc52439282a5f9e4f8fa97e3/metabolic-impact-of-adult-onset-isolated-growth-hormone-deficiency-aoighd-due-to-figure-2.jpg)


![Figure 5 Indirect calorimetry, activity and food/water intake. (A) 48h profiles of respiratory quotient (RQ = VCO2 (ml/min/kg0.75) / VO2 (ml/min/kg0.75) where data was pooled from two separate runs using different mice in each run (n = 10 mice/group total). Comparisons were first made between LF- and HF-fed control mice to verify the accuracy of the gas monitoring system (top panel, 4 months post DT treatment), then AOiGHD mice were compared to controls within diet (LF, 5 months post DT treatment [middle panel] and HF, 5.5 months post DT-treatment [bottom panel]). (B) Percent relative cumulative frequency of 48h RQ values was calculated as reported by Riachi et al [11], and 50th percentile RQ values (values shown adjacent to each curves and demarcated by intercepts of the horizontal solid lines) were compared. (C) Left panels show the mean 48h profiles and right panels show the day and night averages of VO2, VCO2 and energy expenditure (EE, kcal/day/kg0.75) of LF-fed control vs. LF-fed AOiGHD mice conducted in a single run (n = 5 mice/group). (D) Impact of AOiGHD on day and night activity levels. (E) Impact of AOiGHD on 24h ad libitum food and water intake. Asterisks indicate values that differ from controls, *, p<0.05, ** p<0.01, and *** p<0.001.](https://figures.cochat.ai/paper-figures/3f014f4419394a4f9fc2089c52bf781f/metabolic-impact-of-adult-onset-isolated-growth-hormone-deficiency-aoighd-due-to-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Altered body composition, insulin resistance, hypertension, unfavorable lipid profile, endothelial dysfunction and atherosclerosis have been found in several studies on patients with long-term GHD (74,76,77,(82)(83)(84)(85)(86)(87).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [74]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The pathophysiological mechanism of diabetes and insulin resistance in patients with hypopituitarism is not completely understood; however, available evidence suggests GH as the principal player due to its interaction with many other hormonal and/or peptidic systems (74,91).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [74]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hypopituitarism, in general, and GHD, in particular, are associated with a number of metabolic alterations (74 -79).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [74]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751 · cited 1×
“Liver was homogenized in PBS containing protease inhibitors and an aliquot extracted according to the method of Bligh and Dyer [10].”
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038 · cited 1×
“3 program [9].”
Giustina, A., & Veldhuis, J. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0353 · Cited by 1,253 · cited 1×
“Circulating growth hormone (GH) and insulin-like growth factor I (IGF-I) levels steadily rise after birth, plateau around puberty, then decline thereafter at a rate of ,14% for every decade of life [1].”
A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration
Buch, T., Heppner, F. L., Tertilt, C., Heinen, T. J. A. J., Kremer, M., Wunderlich, F. T., Jung, S., & Waisman, A. (2005) · Nature Methods · doi:10.1038/nmeth762 · Cited by 921 · cited 2×
“At 10wk of age, DT was administered by multiple injections, as originally reported [8].”
Self-citationGiustina, A. (1998) · Endocrine Reviews · doi:10.1210/er.19.6.717 · Cited by 489
Scacchi, M., Pincelli, A., & Cavagnini, F. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0800807 · Cited by 316 · cited 4×
“AOiGHD increases fat depot weight but decreases liver weight and TG content As observed in humans with AOGHD [2,45], AOiGHD mice have relatively more fat, compared to GH-intact controls.”
InfluentialBiological effects of growth hormone on carbohydrate and lipid metabolism
Vijayakumar, A., Novosyadlyy, R., Wu, Y., Yakar, S., & LeRoith, D. (2010) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2009.09.002 · Cited by 300 · cited 1×
“Since GH has both lipolytic and anabolic properties [3], it is hypothesized that the decline in GH with age and weight gain is in part responsible for the progression of metabolic disease.”
Luque, R. M., Kineman, R. D., & Tena-Sempere, M. (2007) · Endocrinology · doi:10.1210/en.2007-0500 · Cited by 261 · cited 1×
“3B), as previously reported [13–15].”
Self-citationFan, Y., Menon, R. K., Cohen, P., Hwang, D., Clemens, T., DiGirolamo, D. J., Kopchick, J. J., Le Roith, D., Trucco, M., & Sperling, M. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.014308 · Cited by 255 · cited 2×
“In the liver-specific GHR knockout mice, lipid accumulation was associated with a decrease in TG secretion [49].”
Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1–deficient mice
Yakar, S., Setser, J., Zhao, H., Stannard, B., Haluzik, M., Glatt, V., Bouxsein, M. L., Kopchick, J. J., & LeRoith, D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci17763 · Cited by 252 · cited 2×
“Our results are consistent with reports showing GH-mediated insulin resistance occurs in liver-specific IGF-I knockout (LID) mice, which have a 75% reduction in circulating IGF-I levels leading to a 3–4 fold increase in GH, with no significant alteration in circulating FFA levels [32].”
Cited by
Brain metabolic dysfunction at the core of Alzheimer's disease
de la Monte, S. M., & Tong, M. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.012 · Cited by 461
“Since growth hormone deficiency promotes obesity [102], and obesity promotes insulin resistance and hyperinsulinemia, agingassociated declines in growth hormone could mediate their effects by causing insulin resistance [103].”
BackgroundThe GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations
Berryman, D. E., Glad, C. A. M., List, E. O., & Johannsson, G. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.64 · Cited by 229
Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach
Tanriverdi, F., Schneider, H. J., Aimaretti, G., Masel, B. E., Casanueva, F. F., & Kelestimur, F. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1065 · Cited by 218
The effects of growth hormone on adipose tissue: old observations, new mechanisms
Kopchick, J. J., Berryman, D. E., Puri, V., Lee, K. Y., & Jorgensen, J. O. L. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0280-9 · Cited by 185
The intricate role of growth hormone in metabolism
Vijayakumar, A., Yakar, S., & LeRoith, D. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00032 · Cited by 179
“GH secretion occurs in a pulsatile manner that is primarily regulated by the 180˚ out-of-phase secretion of two neuroendocrine hormones from the hypothalamus, namely, the GH releasing hormone (GHRH) and somatostatin that stimulate and repress GH secretion respectively.”
BackgroundIsolated Growth Hormone Deficiency (GHD) in Childhood and Adolescence: Recent Advances
Alatzoglou, K. S., Webb, E. A., Le Tissier, P., & Dattani, M. T. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1067 · Cited by 134
Programming and regulation of metabolic homeostasis by HDAC11
Sun, L., Marin de Evsikova, C., Bian, K., Achille, A., Telles, E., Pei, H., & Seto, E. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.06.025 · Cited by 125
“In nocturnal animals, such as mice, the metabolic circadian shift in RER ratios from day to night is well-substantiated with the fat utilization during the day and carbohydrate utilization at night [20, 21].”
Fu, Q., Gremeaux, L., Luque, R. M., Liekens, D., Chen, J., Buch, T., Waisman, A., Kineman, R., & Vankelecom, H. (2012) · Endocrinology · doi:10.1210/en.2012-1152 · Cited by 105
Self-citationGranata, R., Gallo, D., Luque, R. M., Baragli, A., Scarlatti, F., Grande, C., Gesmundo, I., Córdoba‐Chacón, J., Bergandi, L., Settanni, F., et al. (2012) · The FASEB Journal · doi:10.1096/fj.11-201343 · Cited by 110
“As previously shown (24), HFD-fed mice consumed more calories than LFD-fed mice; however, energy intake did not significantly differ between obestatintreated and untreated mice across diets (Fig.”
BackgroundMethodSelf-citationDisruption of the GH Receptor Gene in Adult Mice Increases Maximal Lifespan in Females
Junnila, R. K., Duran‐Ortiz, S., Suer, O., Sustarsic, E. G., Berryman, D. E., List, E. O., & Kopchick, J. J. (2016) · Endocrinology · doi:10.1210/en.2016-1649 · Cited by 95
“Similar to aGHRKO, the aforementioned AOiGHD mice (44) are a model of adult-onset reduction of GH action.”
BackgroundInsulin and Growth Hormone Balance: Implications for Obesity
Huang, Z., Huang, L., Waters, M. J., & Chen, C. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.04.005 · Cited by 97
Growth hormone and adipose tissue: Beyond the adipocyte
Berryman, D. E., List, E. O., Sackmann‐Sala, L., Lubbers, E. R., Munn, R. D., & Kopchick, J. J. (2011) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2011.03.002 · Cited by 100
“For example, the AOGHD model shows an increase in the weight of fat depots relative to controls, specifically the SubQ and retroperitoneal depots at both 2 and 7 months post onset of GHD [88].”
InfluentialPituitary stem cells: Where do we stand?
Vankelecom, H. E. J., & Chen, J. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.08.018 · Cited by 91
Self-citationGrowth Hormone’s Effect on Adipose Tissue: Quality versus Quantity
Berryman, D. E., & List, E. O. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081621 · Cited by 86
“Ames, GHA, GHR-/-, AOiGHD and aGHRKO mice have either unchanged or elevated leptin levels, which is partly dependent on age, sex and fat mass accumulation, while total and HMW adiponectin levels are elevated in all of these lines [75,94,105,108,151].”
BackgroundInfluentialRelationships Between Diabetes and Cognitive Impairment
de la Monte, S. M. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.09.006 · Cited by 71
Córdoba‐Chacón, J., Gahete, M. D., Pozo-Salas, A. I., Martínez‐Fuentes, A. J., de Lecea, L., Gracia‐Navarro, F., Kineman, R. D., Castano, J. P., & Luque, R. M. (2011) · Endocrinology · doi:10.1210/en.2011-1542 · Cited by 69
“Other sets of mice were provided: 1) standard chow or a low-fat diet (starting at 4 wk of age; 10% kcal from fat; Research Diets, Gentofte, Denmark) and glucose tolerance test (GTT) and insulin tolerance test (ITT) performed at 15–17 wk of age, or 2) standard chow diet and treated with CST-14 at approximately 20 wk of…”
BackgroundMethodSelf-citationFu, Q., & Vankelecom, H. E. J. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0290 · Cited by 66
“Cre recombinase binds to these sites and excises the STOP sequence, thereby rendering the Cre-, thus the DTR-expressing cells susceptible to ablation by DT through apoptosis [12,15,16].”
Self-citationDuran‐Ortiz, S., List, E. O., Ikeno, Y., Young, J., Basu, R., Bell, S., McHugh, T., Funk, K., Mathes, S., Qian, Y., et al. (2021) · Aging Cell · doi:10.1111/acel.13506 · Cited by 58
Idiopathic adult growth hormone deficiency
Melmed, S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4012 · Cited by 58
“In fact, in a unique transgenic mouse model of selective somatotroph ablation, recapitulating the disorder of isolated GHD, insulin sensitivity was actually enhanced independently of diet (41).”
BackgroundAdiponectin in mice with altered GH action: links to insulin sensitivity and longevity?
Lubbers, E. R., List, E. O., Jara, A., Sackmann‐Sala, L., Córdoba‐Chacón, J., Gahete, M. D., Kineman, R. D., Boparai, R. K., Bartke, A., Kopchick, J. J., et al. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0505 · Cited by 59
“AOiGHD mice (Luque et al. 2011) have a selective destruction of the Cre-inducible diphtheria toxin receptor (iDTR) expressing GH-producing cells of the anterior pituitary following treatment with diphtheria toxin (DT) at 12 weeks of age, which leads to a 60 and 20% reduction in circulating GH and…”
Self-citationWillems, C., Fu, Q., Roose, H., Mertens, F., Cox, B., Chen, J., & Vankelecom, H. E. J. (2015) · Endocrinology · doi:10.1210/en.2015-1741 · Cited by 57
Self-citationOrganoids from pituitary as a novel research model toward pituitary stem cell exploration
Cox, B., Laporte, E., Vennekens, A., Kobayashi, H., Nys, C., Zundert, I. V., Uji‐i, H., Drubbel, A. V., Beck, B., Roose, H., et al. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0462 · Cited by 68
Self-citationGahete, M. D., Córdoba‐Chacón, J., Anadumaka, C. V., Lin, Q., Brüning, J. C., Kahn, C. R., Luque, R. M., & Kineman, R. D. (2011) · Endocrinology · doi:10.1210/en.2011-1447 · Cited by 42
Self-citationGahete, M. D., Córdoba‐Chacón, J., Luque, R. M., & Kineman, R. D. (2012) · Endocrinology · doi:10.1210/en.2012-1849 · Cited by 41
“Therefore, GH deficiency (GHD) is induced by DTmediated destruction of GH-producing cells of the anterior pituitary (9).”
BackgroundMethodSelf-citationMice with gene alterations in the GH and IGF family
Qian, Y., Berryman, D. E., Basu, R., List, E. O., Okada, S., Young, J. A., Jensen, E., Bell, S. R. C., Kulkarni, P., Duran‐Ortiz, S., et al. (2021) · Pituitary · doi:10.1007/s11102-021-01191-y · Cited by 43
“1 3 with mice having a rat Gh promoter/enhancer driven Cre recombinase [168].”
BackgroundUnderstanding the role of growth hormone in situations of metabolic stress
Tavares, M. R., Frazão, R., & Donato, J. (2022) · Journal of Endocrinology · doi:10.1530/joe-22-0159 · Cited by 45
Odle, A. K., Haney, A. C., Allensworth‐James, M. L., Akhter, N., & Childs, G. V. (2014) · Endocrinology · doi:10.1210/en.2014-1172 · Cited by 40
Metabolic alterations in patients who develop traumatic brain injury (TBI)-induced hypopituitarism
Prodam, F., Gasco, V., Caputo, M., Zavattaro, M., Pagano, L., Marzullo, P., Belcastro, S., Busti, A., Perino, C., Grottoli, S., et al. (2013) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2013.04.001 · Cited by 35
Clinical picture and the treatment of TBI-induced hypopituitarism
Caputo, M., Mele, C., Prodam, F., Marzullo, P., & Aimaretti, G. (2019) · Pituitary · doi:10.1007/s11102-019-00956-w · Cited by 34
Al-Samerria, S., & Radovick, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119556 · Cited by 38
GH directly inhibits steatosis and liver injury in a sex-dependent and IGF1-independent manner
Sarmento‐Cabral, A., del Río-Moreno, M., Vazquez-Borrego, M. C., Mahmood, M., Gutiérrez-Casado, E., Pelke, N., Guzman, G., Subbaiah, P. V., Córdoba‐Chacón, J., Yakar, S., et al. (2020) · Journal of Endocrinology · doi:10.1530/joe-20-0326 · Cited by 33
Self-citationCórdoba‐Chacón, J., Gahete, M. D., McGuinness, O. P., & Kineman, R. D. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00420.2014 · Cited by 28
Self-citationExtending lifespan by modulating the growth hormone/insulin-like growth factor-1 axis: coming of age
Duran‐Ortiz, S., List, E. O., Basu, R., & Kopchick, J. J. (2021) · Pituitary · doi:10.1007/s11102-020-01117-0 · Cited by 30
“Similar to aGHRKO mice, the AOiGHD mice also show an obese phenotype, with decreased glucose tolerance (on high fat diet/HFD) and improved insulin sensitivity.”
BackgroundMethodInfluentialMusculoskeletal Effects of Altered GH Action
Young, J. A., Zhu, S., List, E. O., Duran‐Ortiz, S., Slama, Y. B., & Berryman, D. E. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.867921 · Cited by 27
“…| Volume 13 | Article 8679212 mice) (List et al., 2019) and mice with adult GHD via GHR disruption starting at 6 months of age (6mGHRKO) (DuranOrtiz et al., 2021b) or induced somatotroph destruction (Luque et al., 2011; Cordoba-Chacon et al., 2014; Poudel et al., 2021) have recently been developed.”
BackgroundAblation of Leptin Signaling to Somatotropes: Changes in Metabolic Factors that Cause Obesity
Akhter, N., Odle, A. K., Allensworth‐James, M. L., Haney, A. C., Syed, M., Cozart, M. A., Chua, S. C., Kineman, R. D., & Childs, G. V. (2012) · Endocrinology · doi:10.1210/en.2012-1331 · Cited by 25
“Mice with developmental GHD or GH resistance as well as adult-onset isolated GHD mice have been shown to be more insulin sensitive relative to controls (34), consistent with the fact that GH, at least at high levels, reduces insulin sensitivity in humans (68–70) and mice (71).”
BackgroundSelf-citationCórdoba‐Chacón, J., Gahete, M. D., Pokala, N., Geldermann, D., Alba, M., Salvatori, R., Luque, R. M., & Kineman, R. D. (2014) · Endocrinology · doi:10.1210/en.2013-1825 · Cited by 25
Self-citationGrowth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies
Basu, R., Boguszewski, C. L., & Kopchick, J. J. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae030 · Cited by 28
Insulin signaling in the whole spectrum of GH deficiency
Garmes, H. M., & Castillo, A. R. (2019) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000188 · Cited by 25
“These mouse strains, like the GHR -/- strain have low levels of insulin and glycemia, are extremely sensitive to insulin when compared to controls despite having a higher amount of fat, and are also intolerant to glucose due to a decrease in size of the pancreatic islets (46,47).”
BackgroundMethodInfluentialHypothalamic–pituitary organoid generation through the recapitulation of organogenesis
Ozaki, H., Suga, H., & Arima, H. (2021) · Development Growth & Differentiation · doi:10.1111/dgd.12719 · Cited by 21
“…et al., 2001; Gremeaux et al., 2012; Kikuchi et al., 2007; Mollard et al., 2012), after pituitary damage (Fu et al., 2012; Langlais et al., 2013; Luque et al., 2011), and in pituitary tumorigenesis (Andoniadou et al., 2012; Gaston- Massuet et al., 2011; Garcia- Lavandeira et al., 2012; Li,…”
BackgroundDapagliflozin restores insulin and growth hormone secretion in obese mice
Huang, Z., Huang, L., Wang, C., Zhu, S., Qi, X., Chen, Y., Zhang, Y., Cowley, M. A., Veldhuis, J. D., & Chen, C. (2020) · Journal of Endocrinology · doi:10.1530/joe-19-0385 · Cited by 18
“Low GH secretion (Luque et al. 2011) or GH receptor knockout (Cordoba-Chacon et al.”
BackgroundVakili, H., Jin, Y., & Cattini, P. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.380949 · Cited by 17
“This was suggested based on the observation that adult onset isolatedGHdeficiency inmice was associatedwith higher insulin sensitivity (62).”
BackgroundElevated GH/IGF-I promotes mammary tumors in high-fat, but not low-fat, fed mice
Gahete, M. D., Córdoba‐Chacón, J., Lantvit, D. D., Ortega-Salas, R. M., Sánchez‐Sánchez, R., Pérez‐Jiménez, F., López‐Miranda, J., Swanson, S. M., Castano, J. P., Luque, R. M., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu161 · Cited by 18
Self-citationOliveira‐Santos, A. A., Salvatori, R., Santos, E. G., Santana, J. A. M., Leal, Â. C. G. B., Barbosa, R. A. A., Oliveira, C. R. P., Souza, A. H. O., Valença, E. H. O., & Aguiar-Oliveira, M. H. (2015) · Endocrine · doi:10.1007/s12020-015-0670-2 · Cited by 17
Disruption of the GH receptor gene in adult mice and in insulin sensitive tissues
Duran‐Ortiz, S., Noboa, V., & Kopchick, J. J. (2017) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2017.11.003 · Cited by 17
Stem Cells in Neuroendocrinology
Pfaff, D., & Christen, Y. (2016) · Research and perspectives in endocrine interactions · doi:10.1007/978-3-319-41603-8 · Cited by 17
“2012), after pituitary damage (Luque et al. 2011; Fu et al. 2012; Langlais et al. 2013), and in pituitary tumorigenesis (Gaston-Massuet et al.”
BackgroundThe role of growth hormone receptor in β cell function
Wang, S., Wu, J. C., Wang, N., Zeng, L., & Wu, Y. (2017) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2017.08.002 · Cited by 13
Sexual dimorphic impact of adult‐onset somatopause on life span and age‐induced osteoarthritis
Poudel, S. B., Dixit, M., Yildirim, G., Córdoba‐Chacón, J., Gahete, M. D., Ikeno, Y., Kirsch, T., Kineman, R. D., & Yakar, S. (2021) · Aging Cell · doi:10.1111/acel.13427 · Cited by 11
“We have previously shown that administration of DT to adult rGHp- Cre, iDTR mice resulted in the selective destruction of DTR- expressing somatotrophs leading to a sustained reduction in GH to 20%– 30% of age- matched controls, and IGF1 levels F I G U R E 1 Effects of adult- onset isolated growth hormone deficiency (A…”
MethodSelf-citationBerryman, D. E., Henry, B. E., Hjortebjerg, R., List, E. O., & Kopchick, J. J. (2016) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2016.1147950 · Cited by 14
“GHD (AOiGHD), Ames dwarf and Snell dwarf mice, is not uniform with the subQ depot disproportionately enlarged and with minimal changes in the epididymal fat pad [44,49,50,53,55].”
BackgroundPituitary Stem Cells: Quest for Hidden Functions
Vankelecom, H. E. J. (2016) · Research and perspectives in endocrine interactions · doi:10.1007/978-3-319-41603-8_7 · Cited by 14
“Through a transgenic mouse approach, damage was inflicted in the pituitary by killing the somatotrope (GHþ) cells using diphtheria toxin (DT; Fu et al. 2012; Luque et al. 2011).”
MethodSelf-citationModels of GH deficiency in animal studies
Gahete, M. D., Luque, R. M., & Castano, J. P. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.11.001 · Cited by 12
Self-citationDuran‐Ortiz, S., Bell, S. R. C., & Kopchick, J. J. (2018) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2018.08.003 · Cited by 11
Common and Uncommon Mouse Models of Growth Hormone Deficiency
List, E. O., Basu, R., Berryman, D. E., Duran‐Ortiz, S., Martos‐Moreno, G. Á., & Kopchick, J. J. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae017 · Cited by 12
Insulin Resistance and Metabolic Failure Underlie Alzheimer Disease
de la Monte, S. M., & Tong, M. (2013) · Wiley eBooks · doi:10.1002/9781118395318.ch1 · Cited by 10
“Because growth hormone deficiency promotes obesity [122], and obesity promotes insulin resistance and hyperinsulinemia, aging-associated declines in growth hormone could mediate their effects by causing insulin resistance [123].”
BackgroundChanclón, B., Luque, R. M., Córdoba‐Chacón, J., Gahete, M. D., Pozo-Salas, A. I., Castano, J. P., Gracia‐Navarro, F., & Martínez‐Fuentes, A. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057834 · Cited by 9
“These data are in agreement with the elevation of plasma insulin levels in obese animals observed in this study and also documented by others [17,33,35].”
ResultSelf-citationApplication of pluripotent stem cells for treatment of human neuroendocrine disorders
Suga, H. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2880-4 · Cited by 12
Differentiation of Pluripotent Stem Cells into Hypothalamic and Pituitary Cells
Suga, H. (2014) · Neuroendocrinology · doi:10.1159/000369821 · Cited by 8
Bouchoucha, Y. X., Charnay, P., & Gilardi‐Hebenstreit, P. (2012) · Endocrinology · doi:10.1210/en.2012-1792 · Cited by 7
“This is consistent with a recently published adult-onset IGHD model (23), although the responses to insulin and glucose are of a higher magnitude in our mutant, presumably because GHD appears at an earlier stage.”
BackgroundResultInfluentialSanchez-Garrido, M. A., Ruíz-Pino, F., Pozo-Salas, A. I., Castellano, J. M., Vazquez, M. J., Luque, R. M., & Tena‐Sempere, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-70898-y · Cited by 7
Self-citationDuran‐Ortiz, S., Corbin, K. L., Jahan, I., Whitticar, N. B., Morris, S. E., Bartholomew, A., Slepchenko, K. G., West, H. L., Max-Harry, I. M., List, E. O., et al. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00075.2020 · Cited by 6
Adipocyte Versus Somatotrope Leptin: Regulation of Metabolic Functions in the Mouse
Odle, A. K., Allensworth‐James, M. L., Haney, A. C., Akhter, N., Syed, M., & Childs, G. V. (2016) · Endocrinology · doi:10.1210/en.2015-1811 · Cited by 6
Suga, H. (2016) · Research and perspectives in endocrine interactions · doi:10.1007/978-3-319-41603-8_4 · Cited by 8
“2012), after pituitary damage (Luque et al. 2011; Fu et al. 2012; Langlais et al. 2013), and in pituitary tumorigenesis (Gaston-Massuet et al.”
BackgroundLiving Large: What Mouse Models Reveal about Growth Hormone and Obesity
Berryman, D. E., Householder, L. A., Lesende, V. A., List, E. O., & Kopchick, J. J. (2015) · Energy balance and cancer · doi:10.1007/978-3-319-16733-6_4 · Cited by 5
Making pituitary hormone-producing cells in a dish [Review]
Suga, H. (2016) · Endocrine Journal · doi:10.1507/endocrj.ej16-0232 · Cited by 6
“Subsequent studies have discussed their functions during early postnatal pituitary maturation [2-6], after pituitary damage [7-9], and in pituitary tumorigenesis [10-13].”
Lai, Y.-C., Li, H., Wu, T.-J., Jeng, C.-Y., & Chuang, L. (2014) · PPAR Research · doi:10.1155/2014/917823 · Cited by 5
“Studies have documented that insulin sensitivity increased in adults with GHdeficiency [29].”
Backgrounddel Río-Moreno, M., Poudel, S. B., Stilgenbauer, L., Córdoba‐Chacón, J., Sadagurski, M., Kineman, R. D., & Yakar, S. (2025) · GeroScience · doi:10.1007/s11357-025-01816-1 · Cited by 5
“Whole body fat, lean, and water contents were assessed by NMR (Minispec benchtop LF50 Body Composition mice analyzer; Bruker, Billerica, MA, USA), the week prior to euthanasia as previously reported [13, 14].”
Self-citationMulticenter Study on Adult Growth Hormone Level in Postoperative Pituitary Tumor Patients
Cheng, J., Gu, J., Kuang, Y.-Q., Ma, Y., Xia, X., Yang, T., Lu, M., He, W., Sun, Z., & Zhang, Y.-C. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-0334-5 · Cited by 2
“In patients with hormone deficiency after pituitary tumor surgery, the main clinical symptoms manifested as the obvious change of body composition, such as obvious reduction of muscular tissue, and increase of adipose tissue, especially the increase of abdominal adipose tissue, which leads to abdominal obesity [26].”
Biological poisons targeting the pituitary gland: insights across the five kingdoms
Sanchis-Pascual, D., Gómez, R. C., Morillas-Amat, P., Lara-Gálvez, D., Pérez-Cervantes, V., Masdeu-López-Cerón, P., & Merino-Torres, J. F. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1708792 · Cited by 1
Effects of growth hormone-releasing hormone deficiency in mice beyond growth
Recinella, L., Libero, M. L., Brunetti, L., Acquaviva, A., Chiavaroli, A., Orlando, G., Granata, R., Salvatori, R., & Leone, S. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09936-3 · Cited by 1
“Mouse models of GHD (such as Ames and Snell dwarf mice) or GH resistance (GHRKO), as well as with inducible adult GH deficiency (AOiGHD mice) have increased fat mass [46, 134–136].”
Hepatische Effekte von Wachstumshormon auf den Glukosestoffwechsel
Rufinatscha, K., Ress, C., Salzmann, K., Staudacher, G., Tilg, H., & Kaser, S. (2015) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Metabolic responsiveness to growth hormone in children
Decker, R. (2012) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Suga, H., & Ozone, C. (2017) · Springer eBooks · doi:10.1007/978-981-10-3768-9_3
Obesity and the Growth Hormone Axis
Henry, B. E., Jensen, E., List, E. O., & Berryman, D. E. (2018) · Springer eBooks · doi:10.1007/978-3-319-89506-2_12
Integrated pituitary adaptations to the low estrogen state
Miles, T. K., Odle, A. K., Herdman, A. K., Clark, L. G., Byrum, S. D., Lagasse, A., Haney, A. C., MacNicol, A. M., Childs, G. V., & MacNicol, M. C. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1920998
“Table 3 shows the primer sequences (53).”
Metadata
- Authors
- Luque, R. M., Lin, Q., Córdoba-Chacón, J., Subbaiah, P. V., Buch, T., Waisman, A., Vankelecom, H., & Kineman, R. D.
- Affiliations
- University of Illinois Chicago (US)
- University Hospital Zurich (CH)
- Johannes Gutenberg University Mainz (DE)
- KU Leuven (BE)
- Corresponding author
- Kineman, Rhonda D.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-01-19
- Volume
- 6
- Issue
- 1
- Pages
- e15767
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3023710
- OpenAlex
- W2002684589
- Semantic Scholar
- 75f044e1b35e0ed4cc5f7c5f7213edfaa8d8df75
- Cited by
- 73
- References
- 54
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 1 · 2022: 2 · 2021: 6 · 2020: 4 · 2019: 3 · 2018: 5 · 2017: 4 · 2016: 8 · 2015: 5 · 2014: 9 · 2013: 7 · 2012: 9
- FWCI
- 7.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Lirias (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Universidad de Córdoba Insitutional Repository (Universidad de Córdoba) (submittedVersion, cc-by-nc-nd)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Funders
- U.S. Department of Veterans Affairs
- Office of Research and Development
- Vlaamse regering
- National Institutes of Health
- Instituto de Salud Carlos III (FI06/00804)
- National Institute on Aging (R21AG031465, AG031465)
- National Heart, Lung, and Blood Institute (R01HL068585, HL68585, R56HL068585)
- National Institute of Diabetes and Digestive and Kidney Diseases (R21DK078165, DK78165, R01DK088133)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- growth hormone, insulin sensitivity, high-fat diet, energy metabolism, fat mass, liver lipids, glucose clearance, diabetes mellitus, aging, mouse model, Cre-loxP system, diphtheria toxin receptor, insulin-like growth factor I
- MeSH terms
- Animals, Energy Intake, Diet, Disease Models, Animal, Energy Metabolism, Insulin Resistance, Insulin-Like Growth Factor I, Mice, Mutant Strains, Pituitary Gland, Anterior, Growth Hormone, Age of Onset, Intercellular Signaling Peptides and Proteins, Carbohydrate Metabolism, Mice, Rats, Somatotrophs, Heparin-binding EGF-like Growth Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.